KarXT (Karuna Therapeutics) met its primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia, the company has announced. KarXT is an oral coformulation of ...

Add Yahoo as a preferred source to see more of our stories on Google. Katie Melua recently opened up about suffering an acute psychotic breakdown in her 20s. (Getty Images) Being there for a loved one ...

The investigational combination xanomeline-trospium (KarXT) was effective and well tolerated in individuals with schizophrenia who were experiencing acute psychosis, according to the randomized ...

A new study investigated the brain circuits involved in psychosis—a condition characterized by delusions, hallucinations, disorganized thinking and detachment from reality. Andrew Pines, MD, MA, a ...

Introduction Psychotic disorders account for significant morbidity and healthcare costs and yet their pathophysiology remains poorly understood. The National Institute for Health and Care Research ...

As South Africa concludes Youth Month, the Gauteng Department of Health raises alarms over a troubling increase in ...